These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 8618209)

  • 21. Degradation of polydispersed poly(L-lactic acid) to modulate lactic acid release.
    von Recum HA; Cleek RL; Eskin SG; Mikos AG
    Biomaterials; 1995 Apr; 16(6):441-7. PubMed ID: 7654870
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Poly lactic acid based injectable delivery systems for controlled release of a model protein, lysozyme.
    Al-Tahami K; Meyer A; Singh J
    Pharm Dev Technol; 2006 Feb; 11(1):79-86. PubMed ID: 16544911
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oestrone loaded poly(l-lactic acid) microspheres: preparation, evaluation and in vitro release kinetics.
    Parikh BV; Upadrashta SM; Neau SH; Nuessle NO
    J Microencapsul; 1993; 10(2):141-53. PubMed ID: 8331489
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Controlled release of poly-D,L-lactic acid containing bleomycin.
    Nakamura K; Natsugoe S; Kumanohoso T; Aikou T; Shinkawa T; Yamada K; Fukuzaki H
    Anticancer Drugs; 1995 Jun; 6(3):483-7. PubMed ID: 7545481
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [A basic study on usefulness of bleomycin incorporated in poly DL-lactic acid].
    Kumanohoso T; Natsugoe S; Shimada M; Sagara M; Aikou T; Shimazu H; Shinkawa T; Nakamura K; Fukuzaki H
    Gan To Kagaku Ryoho; 1993 Aug; 20(11):1572-4. PubMed ID: 7690536
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ciprofloxacin-impregnated poly-L-lactic acid drug carrier. New aspects of a resorbable drug delivery system in local antimicrobial treatment of bone infections.
    Teupe C; Meffert R; Winckler S; Ritzerfeld W; Törmälä P; Brug E
    Arch Orthop Trauma Surg; 1992; 112(1):33-5. PubMed ID: 1482616
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preparation and evaluation of biodegradable films containing the potent osteogenic compound BFB0261 for localized delivery.
    Umeki N; Sato T; Harada M; Takeda J; Saito S; Iwao Y; Itai S
    Int J Pharm; 2011 Feb; 404(1-2):10-8. PubMed ID: 21047548
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Poly(lactic acid) and poly(lactic-co-glycolic acid) particles as versatile carrier platforms for vaccine delivery.
    Pavot V; Berthet M; Rességuier J; Legaz S; Handké N; Gilbert SC; Paul S; Verrier B
    Nanomedicine (Lond); 2014 Dec; 9(17):2703-18. PubMed ID: 25529572
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel in situ forming drug delivery system for controlled parenteral drug delivery.
    Kranz H; Bodmeier R
    Int J Pharm; 2007 Mar; 332(1-2):107-14. PubMed ID: 17084049
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Preparation of oral sustained-action preparations with a base of biologically degradable polymers. 2. Preparation of matrix tablets with a base of polylactic acid].
    Mank R; Kala H; Richter M
    Pharmazie; 1989 May; 44(5):328-30. PubMed ID: 2772012
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A new vitreal drug delivery system using an implantable biodegradable polymeric device.
    Kimura H; Ogura Y; Hashizoe M; Nishiwaki H; Honda Y; Ikada Y
    Invest Ophthalmol Vis Sci; 1994 May; 35(6):2815-9. PubMed ID: 8188476
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Controlled release of cisplatin incorporated into biodegradable poly-d, l-lactic acid.
    Natsugoe S; Kumanohoso T; Tokuda K; Shimada M; Mueller J; Nakamura K; Yamada K; Fukuzaki H; Aikou T
    Anticancer Res; 1997; 17(3C):1957-60. PubMed ID: 9216651
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Entrapment of proteins in poly(L-lactide) microspheres using reversed micelle solvent evaporation.
    Hayashi Y; Yoshioka S; Aso Y; Li Wan Po A; Terao T
    Pharm Res; 1994 Feb; 11(2):337-40. PubMed ID: 8165198
    [No Abstract]   [Full Text] [Related]  

  • 34. Efficient delivery of antitumor drug to the nuclei of tumor cells by amphiphilic biodegradable poly(L-aspartic acid-co-lactic acid)/DPPE co-polymer nanoparticles.
    Han S; Liu Y; Nie X; Xu Q; Jiao F; Li W; Zhao Y; Wu Y; Chen C
    Small; 2012 May; 8(10):1596-606. PubMed ID: 22411637
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel surfactant for preparation of poly(L-lactic acid) nanoparticles with controllable release profile and cytocompatibility for drug delivery.
    Li F; Zhu A; Song X; Ji L
    Colloids Surf B Biointerfaces; 2014 Mar; 115():377-83. PubMed ID: 24503291
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Poly(lactic acid) microencapsulated oxytetracycline: in vitro and in vivo evaluation.
    Vidmar V; Smolcić-Bubalo A; Jalsenjak I
    J Microencapsul; 1984; 1(2):131-6. PubMed ID: 6336522
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The preparation of poly (DL-lactide) hollow fiber and the release of drug in vitro].
    Zhu J; Shen Z; Ma Z; Wu L; Shi D
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 1997 Sep; 14(3):247-51. PubMed ID: 11326842
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Poly(L-lactic acid) membranes: absence of genotoxic hazard and potential for drug delivery.
    Uzun N; Martins TD; Teixeira GM; Cunha NL; Oliveira RB; Nassar EJ; Dos Santos RA
    Toxicol Lett; 2015 Jan; 232(2):513-8. PubMed ID: 25479058
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The characterization of paclitaxel-loaded microspheres manufactured from blends of poly(lactic-co-glycolic acid) (PLGA) and low molecular weight diblock copolymers.
    Jackson JK; Hung T; Letchford K; Burt HM
    Int J Pharm; 2007 Sep; 342(1-2):6-17. PubMed ID: 17555895
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Preparations of drug-loaded poly(lactic acid) nanoparticles].
    Deng LD; Sun DX; Dong AJ
    Zhongguo Zhong Yao Za Zhi; 2002 Jul; 27(7):496-8. PubMed ID: 12846214
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.